Also trades as: CHG.BK (SET) · $vol 2M
CHG-R.BK SET
Chularat Hospital Public Company Limited
1W: -3.8%
1M: -2.6%
3M: -5.0%
YTD: -7.9%
1Y: -16.0%
3Y: -44.1%
฿1.52 ($0.05)
-0.01 (-0.65%)
Weekly Expected Move ±3.1%
฿1
฿1
฿2
฿2
฿2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$10.2B
-1.4% ▼
5Y CAGR: +10.6%
Total Liabilities
$2.0B
-12.3% ▼
5Y CAGR: -0.3%
Shareholders Equity
$7.8B
+1.3% ▲
5Y CAGR: +14.2%
Cash & Investments
$1.9B
+4.2% ▲
5Y CAGR: +28.0%
Total Debt
$612M
-13.3% ▼
5Y CAGR: -12.3%
Net Debt
-$1.2B
-17.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.8B | $2.0B | $1.4B | $1.7B | $1.8B |
| Short-Term Investments | $0 | $0 | $125M | $120M | $120M |
| Cash & ST Investments | $2.8B | $2.0B | $1.5B | $1.8B | $1.9B |
| Net Receivables | $2.3B | $2.6B | $2.2B | $1.9B | $1.5B |
| Inventory | $295M | $265M | $336M | $300M | $310M |
| Other Current Assets | $180M | $151M | $27M | $51M | $119M |
| Total Current Assets | $5.9B | $5.1B | $4.0B | $4.1B | $3.8B |
| Property, Plant & Equip. | $4.4B | $5.9B | $5.8B | $5.8B | $6.0B |
| Goodwill & Intangibles | $82M | $103M | $159M | $172M | $179M |
| Long-Term Investments | $76M | $142M | $199M | $102M | $165M |
| Other Non-Current Assets | $112M | -$934M | $53M | $144M | $58M |
| Total Non-Current Assets | $4.7B | $5.2B | $6.2B | $6.3B | $6.4B |
| Total Assets | $10.5B | $10.3B | $10.3B | $10.4B | $10.2B |
| — Liabilities — | |||||
| Accounts Payable | $362M | $398M | $430M | $869M | $897M |
| Short-Term Debt | $131M | $465M | $127M | $131M | $152M |
| Deferred Revenue | $1.7B | $272M | $278M | $0 | $0 |
| Other Current Liabilities | $1.5B | $311M | $320M | $374M | $107M |
| Total Current Liabilities | $2.2B | $1.8B | $1.5B | $1.5B | $1.2B |
| Long-Term Debt | $313M | $334M | $556M | $512M | $431M |
| Other Non-Current Liab. | $4M | $223M | $234M | $220M | $280M |
| Total Non-Current Liabilities | $500M | $614M | $849M | $788M | $752M |
| Total Liabilities | $2.7B | $2.4B | $2.3B | $2.3B | $2.0B |
| — Equity — | |||||
| Common Stock | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Retained Earnings | $5.2B | $5.2B | $5.2B | $5.4B | $5.5B |
| Accumulated OCI | $110M | $110M | $110M | $110M | $110M |
| Total Stockholders Equity | $7.6B | $7.5B | $7.5B | $7.7B | $7.8B |
| Total Liabilities & Equity | $10.5B | $10.3B | $10.3B | $10.4B | $10.2B |
| — Key Metrics — | |||||
| Total Debt | $514M | $870M | $750M | $706M | $612M |
| Net Debt | -$2.3B | -$1.1B | -$649M | -$986M | -$1.2B |
| Total Investments | $76M | $142M | $324M | $222M | $285M |